<?xml version="1.0" encoding="UTF-8"?>
<ref id="b47-1040797">
 <label>47.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hillmen</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Janssens</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Babu</surname>
    <given-names>KG</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL</article-title>. 
  <source>Acta Oncol</source>. 
  <year>2016</year>;
  <volume>55</volume>(
  <issue>9–10</issue>):
  <fpage>1115</fpage>–
  <lpage>1120</lpage>.
  <pub-id pub-id-type="pmid">27494089</pub-id>
 </mixed-citation>
</ref>
